Indiana Hemophilia & Thrombosis Center, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.ihtc.org
Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency
Phase 4
Active, not recruiting
- Conditions
- Plasminogen Activator Inhibitor-1 DeficiencyCardiac Fibrosis
- Interventions
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05317806
- Locations
- 🇺🇸
Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, United States
Hemlibra in Mild Hemophilia A
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04567511
- Locations
- 🇺🇸
Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana, United States
HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT03921294
- Locations
- 🇺🇸
Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana, United States
Study of Individuals Affected With Hypoplasminogenemia
Recruiting
- Conditions
- Plasminogen Deficiency
- First Posted Date
- 2019-01-09
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03797495
- Locations
- 🇮🇹
University Hospital of Padova, Padua, Italy
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Stony Brook University | Stony Brook Medicine, East Setauket, New York, United States
© Copyright 2025. All Rights Reserved by MedPath